Vaccination is crucial for avoiding infection-associated morbidity and mortality among
immunocompromised patients. However, immunocompromised patients respond less well to …

Abstract Coronavirus disease 2019 (COVID-19) has several extrapulmonary symptoms.
Gastrointestinal (GI) symptoms are among the most frequent clinical manifestations of …

Importance With a large proportion of the US adult population vaccinated against SARS-
CoV-2, it is important to identify who remains at risk of severe infection despite vaccination …

METHODS: Patients with IBD vaccinated against COVID-19 who consulted for disease flare
between December 1, 2020, and December 31, 2021, were ascertained from the Clinical …

Background Patients on immunosuppressive drugs have been excluded from COVID-19
vaccines trials, creating concerns regarding their efficacy. Aims To explore the humoral …

The vaccination of immunocompromised children against coronavirus disease 2019 is an
important public health issue. We evaluated the serological response, safety, and efficacy of …

Background Beyond systematic reviews and meta-analyses, there have been no direct
studies of serological response to COVID-19 in patients with inflammatory bowel disease …

Abstract SARS-CoV-2-specific CD8+ T cells recognize conserved viral peptides and in the
absence of cross-reactive antibodies form an important line of protection against emerging …

Immunocompromised individuals, primarily attributable to using immunosuppressants, face
heightened COVID-19 risks. Despite the proven efficacy of COVID-19 vaccines, their impact …

Background In 2023, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron variant caused a large-scale outbreak of coronavirus disease 2019 (COVID-19) in …